Advertisement

Topics

Companies Related to "Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer" [Most Relevant Company Matches] RSS

01:41 EDT 24th October 2018 | BioPortfolio

Here are the most relevant search results for "Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Study Bevacizumab Combination With Oxaliplatin External Beam Radiation" Companies 1–25 of 1,000+

Extremely Relevant

E-BEAM Services

E-BEAM Services, Inc. is a leading supplier of contract electron beam processing services, with more than 450kW of installed accelerator capacity -- enough to process nearly one billion pounds of material annually.Based in Cranbury, NJ, E-BEAM was incorporated in 1985 to acquire the radiation service division of a subsidiary of Monsanto.E-BEAM is a privately owned corporation with over 50 employee...


Radiation Therapy Services, Inc.

Radiation Therapy Services, Inc. is a leading developer and operator of radiation therapy centers. These centers, which are freestanding and hospital based, provide a full spectrum of radiation therapy services to cancer patients, including conventional external beam radiation treatments as well as advanced services such as prostate seed implants (brachyth...

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...


Relevant

Huiheng Medical, Inc.

Huiheng Medical, Inc. ("Huiheng") is a leading provider of cancer treatment equipment and after sales service in China. Huiheng develops, markets and sells advanced radiation treatment solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. Huiheng's external beam radiation oncology systems combine integrated CT imaging with stereotactic radios...

IntraOp Medical Corporation

IntraOp Medical Corporation provides innovative technology solutions for the treatment and eradication of cancer. Founded in 1993, IntraOp is committed to providing the tools doctors need to administer intra-operative radiation therapy safely and effectively – for all cancer patients. The company’s flagship product, Mobetron, is the first fully p...

SightLine Health

SightLine Health, headquartered in Houston, Texas, specializes in groundbreaking cancer treatments such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), high-dose-rate (HDR) brachytherapy, and electron-beam radiation therapy. The company opened its first facility, near the renowned Texas Medical Center, in 2005. Today...

Provision Center for Proton Therapy

Opening in early 2014, the Provision Center for Proton Therapy will be the first of its kind in Tennessee and only the second in the Southeast. Proton therapy, the most advanced form of radiotherapy in the world, uses a single beam of high-energy protons to treat various forms of cancer. Different from conventional radiation therapy — in which beam en...

Suitable Technologies, Inc.

The Suitable Technologies Beam product family revolutionizes remote interaction by combining user-controlled device mobility with professional video conferencing for an immersive communication experience. The freedom to select their own path through an environment enables Beam users to be present and to interact naturally from anywhere in the world. Founde...

Beam Global Spirits & Wine, Inc.

Inspiring conversations around the world, Beam Global Spirits & Wine, Inc. is building brands people want to talk about. Consumers from all corners of the globe call for our brands, including Jim Beam(R) Bourbon, Sauza(R) Tequila, Canadian Club(R) Whisky, Courvoisier(R) Cognac, Maker's Mark(R) Bourbon, Laphroaig(R) Scotch Whisky, Cruzan(R) Rum, Larios(R) Gin, Whisky DYC(R), Teacher's(R) Scotch Whi...

Beam Global Spirits & Wine

Inspiring conversations around the world, Beam Global Spirits & Wine, Inc. is building brands people want to talk about. Consumers from all corners of the globe call for our brands, including Jim Beam(R) Bourbon, Sauza(R) Tequila, Canadian Club(R) Whisky, Courvoisier(R) Cognac, Maker's Mark(R) Bourbon, Laphroaig(R) Scotch Whisky, Cruzan(R) Rum, EFFEN(R) Vodka, Larios(R) Gin, Whisky DYC(R), Teacher...

Beam Therapeutics

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Headquartered in Cambridge, Massachusetts, the company is bac...

EBS

Energy Beam Sciences designs, manufactures, and sells quality products for histology, light microscopy, electron microscopy, materials sciences, and the production, control and application of electron beam technology

Oncolytics Biotech Inc.

Oncolytics Biotech Inc. was formed in 1998 to develop its proprietary product, REOLYSIN®, as a potential therapeutic for a wide variety of human cancers. Oncolytics has completed five clinical trials with REOLYSIN® in Canada and the U.K. and is currently conducting four Phase I or Phase I/II REOLYSIN® trials in the U.K. and the U.S. The company also has permission to commence a Phase II combina...

SPECS Scientific Instruments, Inc

SPECS Scientific Instruments, Inc., with over twenty years of experience in the field of Ultra High Vacuum products, is a leading manufacturer and distributor of surface analysis and thin film deposition components and systems for LT-STM, XPS, UPS, ISS, AES, SAM, SEM, LEED, EELS, ARUPS, ARXPS, PEEM, LEEM, SIMS and SNMS, MBE Components, Effusion Cells, K-cells, RF-sources, Plasma Sources, Accelerat...

External Pharma Inc

External Pharma, Inc. provides preclinical drug discovery and development support to pharmaceutical and biotech companies as fee for service or in collaboration with a partner. Our main focus is to evaluate drug candidates and targets for neurological and psychiatric indications. External Pharma represents the next generation of CROs - highly experienced drug development scientists working in a st...

Arizona Oncology Services

Arizona Oncology Services (AOS) provides Radiation Oncology Services at fourteen facilities in the greater Phoenix region and Yuma, which are listed below. Of these facilities eight are owned and operated by AOS, four are Radiation Oncology Departments within hospitals to include St. Joseph's Hospital & Medical Center; Banner Desert Medical Center; Banner Good Samaritan Medical Center; and Banner ...

D3 Radiation Oncology Solutions

D3 Radiation Oncology Solutions has been a trusted source of technical expertise and industry knowledge in radiation oncology since 2001. D3 solutions have been developed with leading experts through its affiliation with UPMC and UPMC Cancer Centers. D3 offers the solutions practices need today for success tomorrow and delivers them with unmatched expertise proven over a decade. From flexible opt...

OneMedNet Corporation

OneMedNet Corporation is a service provider offering BEAM™, an industry-leading technology for the secure sharing of medical imaging information. OneMedNet has been providing medical image sharing anywhere around the world over the Internet since 2010. The unique peer-to-peer transfer technology of BEAM does not use a virtual private network (VPN) or ...

Advanced Radiation Corp

Advanced Radiation Corp is a "lamp" company. Our expertise is based on many years of design and fabrication of advanced light sources for the semiconductor, electro-optical, laser, and printed circuit board industries. Since its inception in 1971, ARC has been a "leader" in developing and manufacturing high quality, high reliability, and fairly priced lamps and ultraviolet radiation sources. Found...

Texas Center for Proton Therapy

Texas Center for Proton Therapy is the North Texas region’s first proton therapy center. The center features latest-generation technology, including pencil-beam scanning and image-guided proton therapy, providing precise radiation treatment with the opportunity to reduce side effects. Opening in late 2015, the facility will provide advanced cancer tre...

Radiation Shield Technologies

Radiation Shield Technologies (RST), with headquarters and manufacturing facilities in Miami, is a global leader in the research, development and production of personal-protection systems. RST’s core technology, Demron, is the world’s first and only fabric that provides complete protection from all nuclear, biological, chemical and bomb and balli...

Ion Beam Applications S.A.

OncoEthix

OncoEthix is a privately held biotechnology company that plans to develop a small portfolio of oncology drug candidates, ensuring a proper foundation for commercial success. The company’s lead product, OTX008, a synthetic small molecule targeted to galectin-1, entered Phase 1 clinical trial in the first quarter of 2012. OncoEthix was incorporated in 2007 and completed a Series A financing ...

Hanmi Pharmaceutical co., Ltd.

Hanmi Pharmaceutical is a Korea-based pharmaceutical company. The Company invests over 20 percent of its sales in R&D and has over 20 programs consisting of the novel long acting biologics including weekly Insulin, weekly to monthly GLP-1, and their combination for diabetes and obesity (collectively referred as Quantum Project), the novel targeted anti-can...

CvergenX

CvergenX, Inc. is an early stage advanced diagnostic services company that was founded to provide personalized medicine tools for the field of radiation oncology. The Company's Intervene XRT testing platform applies genomic analysis to predict a tumor's response to radiation and to assist the oncologist in determining the optimal level of radiation dosing....


More From BioPortfolio on "Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks